Madrigal Pharmaceuticals (MDGL) announced that Carole Huntsman has been appointed Chief Commercial Officer. Huntsman was most recently Senior Vice President, Head of Specialty Care North America and U.S. Country Lead at Sanofi (SNY), where she directed 2,600 team members across multiple product launches in immunology, neurology, oncology, rare diseases, and rare blood disorders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDGL:
- Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer
- Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
- Madrigal Pharmaceuticals reports Q3 EPS ($5.34), consensus ($4.92)
- Roblox upgraded, Bristol Myers downgraded: Wall Street’s top analyst calls
- Inventiva initiated with a Buy at Canaccord